Clinical Guides
Diabetes Insipidus
A clinically focused, India-adapted guide to arginine vasopressin deficiency and resistance, safe investigation of hypotonic polyuria, controlled correction of hypernatraemia, desmopressin stewardship, pregnancy and peri-neurosurgical care.
MedNext Academy | 14 min read
Diabetes Insipidus
A clinically focused, India-adapted guide to arginine vasopressin deficiency and resistance, safe investigation of hypotonic polyuria, controlled correction of hypernatraemia, desmopressin stewardship, pregnancy and peri-neurosurgical care.
Summary
Diabetes insipidus is a water-balance disorder in which the kidney cannot conserve water appropriately. Current terminology distinguishes arginine vasopressin deficiency, traditionally central or cranial diabetes insipidus, from arginine vasopressin resistance, traditionally nephrogenic diabetes insipidus. Both can produce large volumes of dilute urine, intense thirst, nocturia and dehydration, but their causes and definitive treatments differ. Primary polydipsia, osmotic diuresis and urinary frequency are important mimics. A diagnosis therefore starts by proving hypotonic polyuria, not by assuming that every thirsty patient has vasopressin disease.
Most alert patients with intact thirst and unrestricted water access keep serum sodium near normal. Danger emerges when thirst is impaired, water is unavailable, vomiting prevents intake, desmopressin is omitted, or a patient is fasting, sedated or recovering from pituitary surgery. Hypernatraemia in this setting is a medical emergency. Restore circulation first if shocked, calculate and replace water losses in a controlled manner, measure sodium frequently, and coordinate desmopressin with fluid delivery so an abrupt fall in urine output does not cause excessively rapid sodium correction. Water deprivation testing is never an unsupervised home experiment; it can cause severe dehydration and often has limited discrimination in partial disease. Pregnancy can reveal transient vasopressin deficiency through placental vasopressinase and requires endocrine-obstetric assessment. This educational draft supports structured reasoning but cannot replace a patient-specific endocrine, renal, obstetric, intensive-care or neurosurgical plan.
How Common Is It?
Arginine vasopressin deficiency is rare. A major adult clinical review estimates central diabetes insipidus at roughly one person in 25,000, although prevalence varies because registries, diagnostic criteria and terminology differ. Postoperative disease is encountered more often in neurosurgical and endocrine units than in general practice. Transient polyuria may occur after pituitary or suprasellar surgery, while permanent deficiency depends on the lesion, operative extent and hypothalamic-neurohypophyseal injury. A triphasic postoperative pattern can occur: early polyuria, a later antidiuretic phase from stored hormone release, and recurrent permanent deficiency. Counting every postoperative polyuric episode as permanent disease therefore overestimates burden and exposes patients to unnecessary desmopressin.
Vasopressin resistance is less common in specialist polyuria cohorts than primary polydipsia or partial central disease. Hereditary forms usually present in infancy or childhood; acquired resistance is more relevant in adults and is associated with lithium, electrolyte abnormalities, chronic kidney disease, obstruction and tubulointerstitial disease. Gestational diabetes insipidus is uncommon and generally appears in the second or third trimester, but recognition matters because pregnancy normally lowers the osmotic thresholds for thirst and vasopressin release. Indian incidence data are limited, and referral series from tertiary centres cannot represent community prevalence. Epidemiology should guide suspicion rather than serve as a diagnostic shortcut. The practical burden includes missed doses during hospital admission, delayed access to sodium and osmolality testing, medicine stock failures and long travel to pituitary services—preventable system hazards that are not visible in prevalence figures.
Risk Factors
Suspect arginine vasopressin deficiency after pituitary, hypothalamic or suprasellar surgery; traumatic brain injury; craniopharyngioma, germinoma, metastasis or other sellar masses; infiltrative disease such as sarcoidosis or Langerhans-cell histiocytosis; autoimmune infundibulo-neurohypophysitis; infection; vascular injury; or congenital midline and genetic disorders. New polyuria with headache, visual change, growth failure, menstrual disturbance, sexual dysfunction, fatigue or postural symptoms should prompt assessment for a wider hypothalamic-pituitary process rather than isolated treatment of urine volume. Adipsia, impaired consciousness, frailty, cognitive or communication difficulty, fasting and inability to obtain water greatly amplify the risk of hypernatraemic deterioration. Glucocorticoid replacement may unmask polyuria because cortisol deficiency reduces free-water clearance; adrenal safety must be addressed before interpreting a changing urine pattern.
Vasopressin resistance may follow chronic lithium exposure, hypercalcaemia, hypokalaemia, urinary obstruction, sickle-cell disease, amyloidosis, chronic tubulointerstitial or advanced kidney disease, and medicines such as demeclocycline. X-linked AVPR2 and autosomal AQP2 variants cause inherited forms. Primary polydipsia is associated with habitual overdrinking, psychiatric illness and hypothalamic thirst disorders, but psychiatric history must not be used to dismiss organic disease. Pregnancy increases vasopressin degradation through placental cysteine aminopeptidase; risk is higher with multiple gestation and severe liver dysfunction, including pre-eclampsia or HELLP-associated hepatic impairment. A clear drug timeline, obstetric history, family history and operative record are therefore central risk tools. No risk factor confirms the diagnosis, and absence of a posterior-pituitary bright spot on MRI is neither sufficiently specific nor sensitive on its own.
Diagnosis
History
First distinguish true polyuria from urinary frequency. Quantify a measured 24-hour volume, fluid intake, nocturia and onset; adult polyuria is often operationally defined as more than 3 litres daily or over 50 mL/kg/day, but body size, pregnancy, kidney function and solute intake affect interpretation. Ask about thirst, access to water, weight change, vomiting, diarrhoea, confusion, medicines—especially lithium, diuretics and desmopressin—and recent neurosurgery or head injury. Record pituitary, renal, electrolyte, psychiatric and pregnancy features. A patient who is adipsic or cannot drink can be dangerously dehydrated without reporting thirst.
Examination
Assess airway, cognition, volume status, pulse, blood pressure including postural change, mucous membranes, weight and measured input-output. Look for visual-field impairment, cranial neuropathy, features of a sellar mass, hypopituitarism, pregnancy complications and lithium toxicity. Severe volume depletion can reduce filtration so a patient with decompensated disease is not always polyuric at presentation.
Investigations
Confirm hypotonic polyuria with a 24-hour urine collection or reliable inpatient balance and paired serum sodium or osmolality and urine osmolality. Exclude glycosuria and check glucose, urea, creatinine, potassium, calcium and urinalysis. Interpret results before any dynamic test. Supervised water deprivation followed by desmopressin may separate complete forms, but partial deficiency, partial resistance and chronic primary polydipsia overlap; stop for excessive weight loss, rising sodium, clinical instability or protocol thresholds. Hypertonic-saline-stimulated copeptin has greater diagnostic accuracy in expert centres but requires close sodium monitoring and is not widely available. MRI of the hypothalamic-pituitary region and anterior-pituitary tests follow biochemical confirmation or urgent neurological concern.
Differential Diagnosis
Diabetes mellitus and other osmotic diureses are the first exclusions: glucosuria, high urea delivery, mannitol, high-protein feeding and recovery from obstruction or acute kidney injury can all increase urine volume, usually with urine that is not maximally dilute. Diuretics, excess intravenous fluid and mobilization of oedema also create an appropriate water or solute diuresis. Urinary infection, overactive bladder, pregnancy-related frequency, benign prostatic obstruction and nocturnal polyuria cause frequent voiding without a genuinely excessive 24-hour volume. A bladder diary and measured collection prevent a false endocrine label.
Within hypotonic polyuria, distinguish vasopressin deficiency, vasopressin resistance and primary polydipsia. Complete forms are often separable, but partial states overlap because prolonged high intake can wash out the renal medullary gradient and down-regulate concentrating mechanisms. A water-deprivation result should therefore be interpreted with achieved plasma osmolality, urine response, weight and desmopressin response, not a single urine cutoff. Copeptin testing can improve discrimination where the validated assay and monitored stimulation pathway exist. Hypernatraemia with inappropriately dilute urine strongly supports deficient antidiuretic action, whereas low-normal sodium favours excess intake but is not diagnostic.
After neurosurgery, consider expected postoperative fluid administration, hyperglycaemia, diuretics, cerebral salt wasting and the evolving triphasic response. In pregnancy, distinguish gestational vasopressin deficiency from diabetes mellitus, physiological frequency, hyperemesis-related disturbances and kidney disease. Hypercalcaemia and hypokalaemia may themselves cause renal resistance and must be corrected before declaring idiopathic nephrogenic disease. Psychogenic polydipsia is a diagnosis requiring evidence, not a pejorative explanation for unexplained symptoms.
Management
A stable, alert patient with intact thirst should have free access to water, an individualized desmopressin plan if vasopressin deficient, education about hyponatraemia and dehydration, and treatment of the underlying lesion. Use the lowest regimen that controls disruptive polyuria while permitting periodic aquaresis under the endocrine team's plan; continuous antidiuresis plus unrestricted drinking can cause water intoxication. Treat vasopressin resistance by removing a reversible cause where possible: discuss lithium reduction or substitution with psychiatry, correct potassium and calcium, relieve obstruction and manage kidney disease. Lower dietary sodium and excessive protein may reduce solute-driven urine output. Thiazide, amiloride—particularly for lithium-associated disease—and selected prostaglandin-inhibiting strategies require renal, electrolyte and drug-interaction supervision.
Decompensated disease with hypernatraemia needs high-dependency monitoring. If circulation is compromised, restore intravascular volume with 0.9% sodium chloride before free water. Then replace routine needs, estimated deficit and ongoing losses with oral or nasogastric water when safe or an appropriate intravenous fluid. Check sodium every four hours during active resuscitation and at least every twelve hours until stable. Society guidance limits correction in patients with mild or no symptoms to no more than 0.5 mmol/L/hour and 10 mmol/L/24 hours; acute symptomatic hypernatraemia may initially fall by 5 mmol/L in the first hour until symptoms improve, still capped at 10 mmol/L/24 hours. Fluid optimization precedes desmopressin. In known deficiency with excessive dilute urine, 1–2 micrograms IV or IM can be given with close response monitoring; redose only when high-volume dilute urine returns to avoid combined fluid loading and obligate antidiuresis. Pregnancy requires desmopressin, liver and obstetric assessment, sodium surveillance and post-delivery reassessment.
Prescribing Information
Desmopressin is a potent antidiuretic, not a routine fluid prescription. Oral or sublingual, intranasal and injectable preparations have markedly different bioavailability and microgram doses and must never be converted by moving the same numerical dose between routes. Society inpatient guidance lists typical dose ranges of 100–200 micrograms orally or sublingually, 10–20 micrograms intranasally and 1–2 micrograms IV or IM; actual initiation and switching are specialist decisions. Nasal absorption is unreliable with rhinitis, congestion, nasal surgery or impaired technique. Tablets may be less reliably retained during vomiting. Document the formulation, route, dose, timing, indication and a sodium-monitoring plan, and provide uninterrupted ward access because omission can cause severe dehydration.
The principal toxicity is dilutional hyponatraemia from antidiuresis plus excessive fluid intake. Warn about headache, nausea, confusion, seizures and sudden weight gain; review dose, drinking behaviour, renal function and interacting medicines if sodium falls. Patients should not independently double a missed dose or repeatedly take extra doses for persistent thirst without assessing urine output and seeking advice. Planned delayed or omitted doses to permit aquaresis may reduce water retention, but the schedule must be individualized; it is unsafe in adipsia, acute illness or patients unable to respond to thirst.
In emergency hypernatraemia, coordinate each parenteral dose with fluid balance and serial sodium. A sharp fall in urine output after desmopressin can rapidly convert ongoing fluid replacement into positive balance. Pregnancy-associated deficiency generally responds because desmopressin resists placental vasopressinase; requirements can change and frequently fall after delivery. Thiazides, amiloride and non-steroidal anti-inflammatory drugs for resistant disease require monitoring of blood pressure, sodium, potassium and kidney function, with additional gastrointestinal and cardiovascular risk appraisal.
When to Refer
Refer suspected hypotonic polyuria to endocrinology when initial measurements confirm excessive dilute urine, when paired serum and urine results are discordant, or when dynamic testing is being considered. Water deprivation and hypertonic-saline copeptin testing belong in experienced units with defined stopping criteria, immediate biochemistry and rescue treatment. Urgent endocrine and neurosurgical or neuro-oncology review is needed for a sellar or suprasellar lesion, new visual-field loss, cranial nerve deficit, severe headache, multiple pituitary deficits, germinoma concern or evolving postoperative fluid disturbance. Coordinate cortisol assessment and replacement because adrenal insufficiency can be fatal and its treatment can reveal previously masked polyuria.
Every hospital admission of a patient taking desmopressin should trigger medication reconciliation and an endocrine plan. High-dependency or intensive care is appropriate for severe hypernatraemia, shock, impaired consciousness, seizures, inability to drink, adipsia or sodium changing despite treatment. Nephrology should join when chronic kidney disease, lithium nephrotoxicity, obstruction, persistent vasopressin resistance or complex electrolyte replacement limits the standard pathway. Psychiatry collaboration is required before changing lithium and when primary polydipsia is possible, without allowing diagnostic overshadowing.
Pregnancy-associated symptoms require joint endocrinology and maternal-fetal medicine assessment, particularly with hypertension, liver dysfunction, multiple pregnancy or suspected hypophysitis. Paediatric-onset disease, familial polyuria or congenital features merits paediatric endocrinology and genetic evaluation. In India, early referral to a centre that can provide paired osmolality, pituitary MRI and neurosurgical review may be safer than attempting poorly supervised dynamic testing where rapid sodium assays or monitored beds are unavailable.
Red Flags
Treat reduced consciousness, seizures, shock, severe weakness, rapidly rising sodium or sodium above 160 mmol/L as an emergency. Moderate hypernatraemia is also dangerous when water access is impaired. Do not be reassured by an absent large urine output in a severely volume-depleted patient: low renal perfusion can temporarily mask the expected diuresis. A sudden high-volume, very dilute urine after resuscitation, glucocorticoid treatment or neurosurgery demands immediate sodium and fluid review. Equally, falling sodium, headache, vomiting, behavioural change or seizure after desmopressin suggests water intoxication and requires urgent assessment rather than another dose.
After pituitary or suprasellar surgery, red flags include hourly polyuria with rising sodium, missed desmopressin, inability to drink, new visual symptoms, cerebrospinal-fluid leak, fever or neurological decline. During the later antidiuretic phase of a triphasic response, continuing a dose established during early polyuria may cause profound hyponatraemia; surveillance must continue even when urine output appears to normalize. Patients fasting for theatre need a written plan covering route and timing of desmopressin, intravenous fluid and sodium sampling.
In pregnancy, new intense thirst and polyuria with hypernatraemia, headache, visual change, hypertension, right-upper-quadrant pain or abnormal liver tests warrants urgent obstetric-endocrine assessment. Severe vomiting can prevent both water and oral medicine retention. At home, inability to access water, prolonged diarrhoea or vomiting, confusion, or repeated failure to retain desmopressin should trigger emergency care. These signs reflect failures of water balance that can evolve within hours, not routine inconvenience from nocturia.
Indian Clinical Context
The essential diagnostic pathway can be delivered in India without advanced biomarkers: verify 24-hour urine volume, obtain paired serum sodium or measured plasma osmolality and urine osmolality, exclude glucose and electrolyte causes, then obtain pituitary imaging and hormone assessment when indicated. However, urine osmolality, measured serum osmolality and copeptin are unevenly available. Laboratories may report calculated osmolality or urine specific gravity instead; these are useful screening aids but should not be silently substituted for a validated dynamic-test protocol. Record sample time, fluid status and desmopressin exposure so results from different laboratories remain interpretable. Hypertonic-saline copeptin testing should not be improvised without the assay, rapid sodium turnaround and monitored rescue capability.
Pituitary and skull-base surgery is concentrated in tertiary centres. A patient travelling from a district facility needs a transfer note stating recent hourly urine output, fluids, sodium trend, cortisol status and every desmopressin dose. Stocking failures are a clinical risk: hospitals should ensure injectable and enteral formulations are obtainable and should not ask families to source emergency medicine while sodium rises. An affordable written plan should include generic name, formulation, route, storage instructions, local emergency contact and sick-day rules in the patient's preferred language.
During heat exposure, fasting, long travel or gastrointestinal illness, water loss and interrupted access can destabilize disease quickly. Counsel without assuming that commercially marketed electrolyte drinks are appropriate; fluid choice depends on sodium, circulation and ongoing losses. Pregnancy care should integrate obstetric liver and blood-pressure assessment. Where endocrinology or neurosurgery is distant, stabilize circulation, monitor sodium frequently, obtain telephone specialist advice and transfer early rather than performing water deprivation or repeated empiric desmopressin in an unmonitored bed.
NMC Competency Mapping
This topic integrates physiology, medicine, pharmacology, biochemistry, obstetrics and surgery. Learners should explain vasopressin synthesis, osmotic and non-osmotic release, V2-receptor signalling, aquaporin-2 trafficking, the countercurrent concentrating mechanism and thirst. NMC Physiology renal-system competencies include discussion of renal function testing, and the endocrine-system tables cover hypothalamic-pituitary regulation; these provide the foundation for interpreting paired plasma and urine osmolality rather than memorizing isolated cutoffs. Medicine learning should connect measured polyuria, volume examination, sodium disorders, endocrine history and imaging to a safe differential diagnosis.
A competent undergraduate should be able to obtain an accurate fluid and medicine history, identify dehydration and altered consciousness, order glucose, electrolytes, renal function and urine studies, recognize when dynamic testing is unsafe, and escalate a patient with hypernatraemia. Pharmacology mapping includes route-dependent desmopressin dosing, adverse effects, missed-dose harm and monitoring. Obstetric integration includes placental vasopressinase, pregnancy's lower sodium set point and the need to assess liver and hypertensive disease. Surgical integration includes the postoperative triphasic response, cortisol interaction and a documented fasting plan.
Clinical reasoning can be assessed with a station that provides serial urine volume, sodium and osmolality after pituitary surgery and asks for immediate actions, not merely the name of the condition. The learner should prioritize circulation and controlled free-water replacement, request endocrine-neurosurgical help and coordinate desmopressin with sodium surveillance. Exact competency codes and required certification levels should be verified against the institution's current NMC CBME implementation rather than inferred from an examination-coaching list.
Key Exam Pearls for NEET PG
Diabetes insipidus means hypotonic polyuria, not urinary frequency and not glycosuria. Prove volume first. Central disease reflects insufficient vasopressin; nephrogenic disease reflects renal resistance. In complete central disease, urine remains dilute during deprivation and concentrates after desmopressin; in complete resistance, it remains dilute after desmopressin. Partial states and chronic primary polydipsia overlap, which is why a single water-deprivation cutoff is not infallible. A high baseline copeptin can identify marked resistance, while hypertonic-saline-stimulated copeptin improves separation of central deficiency from primary polydipsia in expert practice.
High serum sodium with inappropriately dilute urine is a major clue. Normal sodium does not exclude disease when thirst and water access compensate. Hypercalcaemia and hypokalaemia cause acquired renal resistance; lithium is the classic medicine, and amiloride is especially relevant to lithium-associated disease. Desmopressin treats central and gestational disease but can cause severe hyponatraemia. Routes are not dose-equivalent. In decompensated central disease, restore circulation before free water, optimize fluid before desmopressin, sample sodium every four hours during resuscitation, and avoid correction above 0.5 mmol/L/hour or 10 mmol/L/day when symptoms are absent or mild.
After pituitary surgery, remember the triphasic response: early deficiency, transient antidiuresis, then possible permanent deficiency. Adrenal insufficiency can mask polyuria; glucocorticoid replacement may unmask it. Gestational disease results from placental vasopressinase, often in later pregnancy, and responds to desmopressin because the analogue resists degradation. The safest exam answer for water deprivation is supervised specialist testing with weight, sodium, osmolality and explicit stop rules—not advice to stop drinking at home.
Frequently Asked Questions
Can diabetes insipidus be excluded when the serum sodium is normal?
No. An alert person with intact thirst and unrestricted access to water can replace urinary losses and maintain a normal sodium despite substantial vasopressin deficiency or resistance. Diagnosis depends on proving hypotonic polyuria and interpreting paired blood and urine measurements. Hypernatraemia instead suggests that compensation has failed because thirst, access, intake or treatment is impaired.
Is it safe to perform a water deprivation test at home?
No. Fluid deprivation can cause rapid weight loss and dangerous hypernatraemia, particularly in complete vasopressin deficiency or impaired thirst. The formal test requires baseline hydration, serial weight, urine output and osmolality, rapid blood testing, explicit stopping criteria and access to desmopressin and rehydration. In obvious hypernatraemic hypotonic polyuria, deliberate deprivation is unnecessary and unsafe.
Why can desmopressin make hypernatraemia correction unexpectedly rapid?
Desmopressin can abruptly stop a large dilute urine loss. If substantial oral or intravenous free water continues at the previous replacement rate, retained water may lower sodium too quickly and later cause hyponatraemia. Fluid restoration therefore comes first, sodium and urine output are checked frequently, and further desmopressin is considered when high-volume dilute urine returns rather than given automatically.
How is diabetes insipidus managed during pregnancy?
Pregnancy can uncover pre-existing partial deficiency or cause transient disease through placental vasopressinase, often later in gestation. Desmopressin is resistant to that enzyme and is the usual replacement, but dose and fluid intake require specialist monitoring. Endocrine-obstetric assessment should also look for pre-eclampsia, HELLP or other liver dysfunction, hypophysitis and additional pituitary hormone deficits.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic